Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Galectin Therapeutics Inc. - Common Stock (NQ:GALT)

4.030 -0.130 (-3.12%)
Streaming Delayed Price Updated: 3:53 PM EST, Jan 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Galectin Therapeutics Inc. - Common Stock

< Previous 1 2 3 Next >
News headline image
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session. ↗
Let's have a look at what is happening on the US markets one hour before the close of the markets on Friday. Below you can find the top gainers and losers in today's session. 
Via Chartmill
News headline image
Which stocks are moving on Friday? ↗
Keep an eye on the top gainers and losers in Friday's session, as they reflect the most notable price movements. 
Via Chartmill
Why Did GALT Shares Plummet Over 30% Today? ↗
Via Stocktwits
News headline image
Which stocks are gapping on Friday? ↗
Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Friday. Let's explore the market movements and identify the stocks with significant gaps. 
Via Chartmill
News headline image
Galectin Therapeutics: Q3 Earnings Insights ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
 
Via Benzinga
News headline image
Stitch Fix Posts Q4 Results, Joins Transocean, MBX Biosciences And Other Big Stocks Moving Lower In Thursday's Pre-Market Session ↗
U.S. stock futures were mixed this morning, with the Dow futures gaining around 0.1% on Thursday. Shares of Stitch Fix, Inc. (NASDAQ: SFIX) dipped 7.6% to $5.21 in pre-market trading following the... 
Via Benzinga
Topics Stocks
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
 
Via Benzinga
News headline image
Galectin Beats Q2 Loss Estimates ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
 
Via Benzinga
News headline image
These stocks are moving in today's session ↗
Let's have a look at what is happening on the US markets in the middle of the day on Friday. Below you can find the top gainers and losers in today's session. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
 
Via Benzinga
News headline image
These stocks are moving in today's session ↗
Intrigued by the market activity one hour before the close of the markets on Tuesday? Uncover the key winners and losers of today's session in our insightful analysis. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
 
Via Benzinga
News headline image
Which stocks are moving on Tuesday? ↗
Keep an eye on the top gainers and losers in Tuesday's session, as they reflect the most notable price movements. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Dow Surges Over 600 Points, Gold Jumps 1.5% ↗
 
Via Benzinga
Topics Stocks
News headline image
Nasdaq Jumps Over 300 Points, Novo Nordisk Shares Spike Higher ↗
 
Via Benzinga
News headline image
Dow Surges 100 Points, Carnival Earnings Top Views ↗
 
Via Benzinga
Topics Stocks
News headline image
Why Is Small Cap Galectin Therapeutics Stock Trading Lower On Friday? ↗
Galectin Therapeutics' NAVIGATE trial shows belapectin reduces varices in MASH cirrhosis, but falls short of statistical targets; full data due in early 2025. 
Via Benzinga
News headline image
GALT Stock Earnings: Galectin Therapeutics Misses EPS for Q2 2024 ↗
GALT stock results show that Galectin Therapeutics missed analyst estimates for earnings per share the second quarter of 2024. 
Via InvestorPlace
News headline image
Galectin Therapeutics And 2 Other Stocks Under $5 Insiders Are Buying ↗
 
Via Benzinga
News headline image
GALT Stock Earnings: Galectin Therapeutics Misses EPS for Q1 2024 ↗
GALT stock results show that Galectin Therapeutics missed analyst estimates for earnings per share the first quarter of 2024. 
Via InvestorPlace
News headline image
Galectin Therapeutics And 2 Other Penny Stocks Insiders Are Buying ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
 
Via Benzinga
News headline image
GALT Stock Earnings: Galectin Therapeutics Meets EPS for Q4 2023 ↗
GALT stock results show that Galectin Therapeutics met analyst estimates for earnings per share the fourth quarter of 2023. 
Via InvestorPlace
News headline image
Madrigal Pharmaceuticals Wins Approval for the First Drug Targeting the Multibillion-Dollar NASH Market. Is the Stock a Screaming Buy? ↗
Madrigal's Rezdiffra will have the NASH market all to itself -- at least for a while. 
Via The Motley Fool
News headline image
More Personal Portfolio: Biotech, Commodities, And Gold ↗
In a few years we will know if that was an extraordinarily opportunistic moment, or a long and frustrating rabbit hole. 
Via Talk Markets
News headline image
Galectin Therapeutics And 3 Other Stocks Under $2 Insiders Are Buying ↗
The Dow Jones closed higher by more than 150 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... 
Via Benzinga
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.